Discovery and optimization of a series of liver X receptor antagonists

被引：16

作者：

Jiao, XianYun ^{[1
]}

Kopecky, David J. ^{[1
]}

Fisher, Ben ^{[1
]}

Piper, Derek E. ^{[2
]}

Labelle, Marc ^{[1
]}

McKendry, Sharon ^{[1
]}

Harrison, Martin ^{[2
]}

Jones, Stuart ^{[2
]}

Jaen, Juan ^{[1
]}

Shiau, Andrew K. ^{[3
]}

Escaron, Patrick ^{[3
]}

Danao, Jean ^{[3
]}

Chai, Anne ^{[3
]}

Coward, Peter ^{[3
]}

Kayser, Frank ^{[1
]}

机构：

[1] Amgen Inc, Dept Med Chem, San Francisco, CA 94080 USA

[2] Amgen Inc, Dept Mol Struct & Characterizat, San Francisco, CA 94080 USA

[3] Amgen Inc, Dept Metab Disorders, San Francisco, CA 94080 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2012年 / 22卷 / 18期

关键词：

LXR alpha/beta; Antagonist; GAL4 reporter gene assay; mSREBP-1c reporter; Conversion; LXR-ALPHA; DEFICIENT MICE; CHOLESTEROL; GENE; LIGAND; BETA; AGONISTS; ATHEROSCLEROSIS; MODULATORS; PROMOTER;

D O I：

10.1016/j.bmcl.2012.07.048

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The present report describes our efforts to convert an existing LXR agonist into an LXR antagonist using a structure-based approach. A series of benzenesulfonamides was synthesized based on structural modification of a known LXR agonist and was determined to be potent dual liver X receptor (LXR alpha/beta) ligands. Herein we report the identification of compound 54 as the first reported LXR antagonist that is suitable for pharmacological in vivo evaluation in rodents. (C) 2012 Published by Elsevier Ltd.

引用

页码：5966 / 5970

页数：5

共 50 条

[1] Discovery and Synthesis of a Novel Series of Liver X Receptor Antagonists
Nian, Siyun
Gan, Xia
Tan, Xiangduan
Yu, Zhenpeng
Wang, Panfeng
Chen, Xing
Wang, Guoping
CHEMICAL & PHARMACEUTICAL BULLETIN, 2015, 63 (08) : 628 - 635
[2] Discovery and optimization of a novel series of liver X receptor-α agonists
Li, LP
Liu, JW
Zhu, LS
Cutler, S
Hasegawa, H
Shan, B
Medina, JC
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (06) : 1638 - 1642
[3] Discovery of Tertiary Sulfonamides as Potent Liver X Receptor Antagonists
Zuercher, William J.
Buckholz, Richard G.
Campobasso, Nino
Collins, Jon L.
Galardi, Cristin M.
Gampe, Robert T.
Hyatt, Stephen M.
Merrihew, Susan L.
Moore, John T.
Oplinger, Jeffrey A.
Reid, Paul R.
Spearing, Paul K.
Stanley, Thomas B.
Stewart, Eugene L.
Willson, Timothy M.
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (08) : 3412 - 3416
[4] Discovery of a new binding mode for a series of liver X receptor agonists
Kopecky, David J.
Jiao, Xian Yun
Fisher, Ben
McKendry, Sharon
Labelle, Marc
Piper, Derek E.
Coward, Peter
Shiau, Andrew K.
Escaron, Patrick
Danao, Jean
Chai, Anne
Jaen, Juan
Kayser, Frank
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (07) : 2407 - 2410
[5] Discovery and optimization of benzimidazole derivatives as a novel chemotype of farnesoid X receptor (FXR) antagonists
Teno, Naoki
Iguchi, Yusuke
Yamashita, Yukiko
Mori, Nobuhiro
Une, Mizuho
Nishimaki-Mogami, Tomoko
Gohda, Keigo
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (06) : 1787 - 1794
[6] Selective ET(A) receptor antagonists discovery of two series of compounds derived from directed screening and their subsequent optimization
Astles, PC
Harris, NV
Harper, MF
Lewis, R
Majid, T
McCarthy, C
McLay, I
Porter, B
Smith, C
Walsh, RJA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 19 - MEDI
[7] Discovery and pharmacological evaluation of a novel series of adamantyl cyanoguanidines as P2X7 receptor antagonists
O'Brien-Brown, James
Jackson, Alexander
Reekie, Tristan A.
Barron, Melissa L.
Werry, Eryn L.
Schiavini, Paolo
McDonnell, Michelle
Munoz, Lenka
Wilkinson, Shane
Noll, Benjamin
Wang, Shudong
Kassiou, Michael
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 130 : 433 - 439
[8] Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3
Johnson, Michael
Li, An-Rong
Liu, Jiwen
Fu, Zice
Zhu, Liusheng
Miao, Shichang
Wang, Xuemei
Xu, Qingge
Huang, Alan
Marcus, Andrew
Xu, Feng
Ebsworth, Karen
Sablan, Emmanuel
Danao, Jay
Kumer, Jeff
Dairaghi, Dan
Lawrence, Chris
Sullivan, Tim
Tonn, George
Schall, Thomas
Collins, Tassie
Medina, Julio
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (12) : 3339 - 3343
[9] Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ETA receptor selectivity
Boyd, SA
Mantei, RA
Tasker, AS
Liu, G
Sorensen, BK
Henry, KJ
von Geldern, TW
Winn, M
Wu-Wong, JSR
Chiou, WJ
Dixon, DB
Hutchins, CW
Marsh, KC
Nguyen, E
Opgenorth, TJ
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (06) : 991 - 1002
[10] Novel series P2X3 receptor antagonists: Discovery of potent and orally efficacious pyrrolinone derivatives
Asahi, Kentaro
Kameyama, Takayuki
Horiguchi, Tohru
Oohara, Miho
Tada, Yukio
Tobinaga, Hiroyuki
Kurihara, Naoko
Kanda, Yasuhiko
Tomari, Maki
Tanaka, Yoshikazu
Takahashi, Fumiyo
Yagi, Shigenori
Shigetoshi, Emiko
Takahara, Yukio
Takeyama, Chie
Tsuji, Hiroki
Yamamoto, Shoichi
Shinohara, Shunji
Kai, Hiroyuki
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245

← 1 2 3 4 5 →